Progression of transthyretin amyloid neuropathy after liver transplantation

Neurology

Volumn 75, Issue 4, 2010, Pages 324-327

  Liepnieks, Juris J ^a   Zhang, Lucy Q ^a   Benson, Merrill D ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMYLOID; PREALBUMIN;

ADULT; AGED; AMINO ACID SEQUENCE; AMYLOID NEUROPATHY; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; HUMAN; LIVER TRANSPLANTATION; PRIORITY JOURNAL; SCIATIC NERVE;

AGED; AGED, 80 AND OVER; AMYLOID; AMYLOID NEUROPATHIES; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; HETEROZYGOTE; HUMANS; LIVER; LIVER TRANSPLANTATION; MIDDLE AGED; PERIPHERAL NERVES; PREALBUMIN;

EID: 77955156168     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181ea15d4     Document Type: Article

References (15)

1. Benson MD, Kincaid JC. Invited review: the molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007;36:411-423.
2. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid J Protein Folding Disord 2003;10:160-184.
3. Holmgren G, Ericzon B-G, Groth C-G, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341:1113-1116.
4. Holmgren G, Steen L, Ekstedt J, Groth CG, et al. Biochemical effect of liver transplantation in two Swedish, patients with familial amyloidotic polyneuropathy (FAP-met30), Clin Genet, 1991, 40, 242-246
5. Pomfret EA, Lewis WD, Jenkins RL, et al. Effect of ortho-topic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998;65: 918-925.
6. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk R. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997;64:74-80. (Pubitemid 27327203)
7. Stangou AJ, Hawkins PN, Heaton ND, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implication for amyloid fibrillogenesis. Transplantation 1998;66:229-233.
8. Olofsson B-O, Backman C, Karp K, Suhr O. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002;73:745-751.
9. Westermark P, Sletten K, Johansson B, Cornwell GG. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990; 87:2843-2845.
10. Liepnieks JJ, Wilson DL, Benson MD. Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis. Amyloid 2006;13:170-177.
11. Yazaki M, Mitsuhashi S, Tokuda T, et al. Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients. Am J Transplant 2007;7:235-242.
12. Liepnieks JJ, Benson MD. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid 2007;14:277-282.
13. Yazaki M, Liepnieks JJ, Kincaid JC, Benson MD. Contribution of wild-type transthyretin (TTR) to hereditary peripheral nerve amyloid. Muscle Nerve 2003;28:438-442.
14. Herlenius G, Wilczek HE, Larsson M, Ericzon BG. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation 2004;77:64-71.
15. Said G, Planté-Bordeneuve V. Familial amyloid polyneu-ropathy: a clinico-pathologic study. J Neurol Sci 2009; 284:149-154.